Reimagine the ‘new normal’ of HCP engagement

Marketing & Strategy: The greatest danger in times of turbulence is not the turbulence, it is to act with yesterday’s logic. Peter Drucker

As a result of COVID-19, the traditional HCP customer engagement models are evolving into a ‘new normal’.

In a recent interview with Health Industry Hub, Ross Murray, Strategic Partnership Director at Australian Doctor Group (ADG), discussed the emerging trends in customer engagement, the future of face-to-face HCP interactions and the impact of digital marketing and personalised content delivery on brand management.

1. What are the key emerging trends impacting clinicians and how does this influence pharma’s marketing and commercial engagement with HCPs?
2. How can companies bridge the gap between f2f and virtual engagement to achieve a sustainable competitive advantage in the ‘new normal’?
3. How are innovative brands leveraging data and analytics to understand where digital marketing is influencing HCP behaviour in order to complement field force activity and drive ROI?
4. What are the key barriers to delivering and optimising content in an agile manner to meet clinician needs?
5. How does digital unlock more value from pharma marketing investments?